SCHEMBL9973671

SCHEMBL9973671

C=C1C=C2[C@@]3(C)C(CC[C@@]2(C)[C@H](c2ccoc2)O1)[C@@]1(C)C=CC(=O)C(C)(C)C1C[C@H]3OC(C)=O

nearest known ligand 0.85

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 10/20 0.85
▸ SLCO1B3 Q9NPD5 7/20 0.85
▸ SLCO1B1 Q9Y6L6 7/20 0.85
▸ SMN1; SMN2 Q16637 6/20 0.85
▸ TP53 P04637 4/20 0.85
▸ TDP1 Q9NUW8 2/20 0.85
▸ USP2 O75604 6/20 0.65
▸ MAPT P10636 4/20 0.65
▸ ALDH1A1 P00352 3/20 0.65
▸ LMNA P02545 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ HPGD P15428 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ MIF P14174 1/20 0.56
▸ GSK3B P49841 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17616912 0.92 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53
SCHEMBL9973669 0.92 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53
SCHEMBL20639350 0.92 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53
SCHEMBL598727 0.92 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53
SCHEMBL14197006 0.92 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53
SCHEMBL10019478 0.92 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53
SCHEMBL17368654 0.87 CYP3A4 (0.74) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53
Azadiradione SCHEMBL19588462 0.85 CYP3A4 (0.77) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53
Azadiradione SCHEMBL29398035 0.85 CYP3A4 (0.77) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53
Azadiradione SCHEMBL15941112 0.85 CYP3A4 (0.77) CYP3A4SLCO1B3SLCO1B1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609870-B2 Treating various disorders using TrkB agonists EMORY UNIVERSITY (US) 2013-12-17 — — US disclosed
US-8203009-B2 Neurotrophic activity of deoxygedunin EMORY UNIVERSITY (US) 2012-06-19 — — US disclosed
Send feedback